Overview

GIST Oral Paclitaxel(Liporaxel)

Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of Liporaxel for patients with GIST who failed on prior standard treatments, including imatinib, sunitinib, and regorafenib, and with low P-glycoprotein expression.
Phase:
PHASE2
Details
Lead Sponsor:
Asan Medical Center